Rapid Acting Insulin Market Share, Size, Growth, Opportunity and Forecast 2024-2032

Imracrahul31 Jul, 2024Other

The global rapid acting insulin market size reached US$ 7.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. The increasing risks of severity and mortality among patients, the growing focus on personalized medicine among the masses, and the increasing investments in research and development (R&D) activities are some of the major factors propelling the market.